IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 51 filers reported holding IGM BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,413,960 | +0.1% | 289,097 | +10.7% | 0.00% | – |
Q2 2023 | $2,411,328 | -23.6% | 261,249 | +13.7% | 0.00% | – |
Q1 2023 | $3,157,534 | -59.0% | 229,806 | -49.2% | 0.00% | – |
Q4 2022 | $7,693,794 | +52.4% | 452,310 | +103.8% | 0.00% | – |
Q3 2022 | $5,047,000 | +49.5% | 221,950 | +18.5% | 0.00% | – |
Q2 2022 | $3,376,000 | -26.4% | 187,261 | +9.1% | 0.00% | – |
Q1 2022 | $4,586,000 | -78.6% | 171,582 | -76.6% | 0.00% | -100.0% |
Q4 2021 | $21,461,000 | -50.3% | 731,720 | +11.5% | 0.00% | -50.0% |
Q3 2021 | $43,140,000 | -11.6% | 656,023 | +11.8% | 0.00% | -33.3% |
Q2 2021 | $48,825,000 | -7.4% | 586,838 | -14.6% | 0.00% | 0.0% |
Q1 2021 | $52,703,000 | +9.6% | 687,215 | +26.2% | 0.00% | 0.0% |
Q4 2020 | $48,080,000 | +97.9% | 544,573 | +65.4% | 0.00% | +50.0% |
Q3 2020 | $24,296,000 | +8.7% | 329,166 | +7.5% | 0.00% | 0.0% |
Q2 2020 | $22,346,000 | +358.4% | 306,116 | +252.6% | 0.00% | – |
Q1 2020 | $4,875,000 | +133.3% | 86,813 | +58.5% | 0.00% | – |
Q4 2019 | $2,090,000 | – | 54,775 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copernicus Capital Management, LLC | 4,000 | $353,000 | 5.50% |
Redmile Group, LLC | 3,425,455 | $302,433,000 | 3.66% |
Artal Group S.A. | 1,200,000 | $105,948,000 | 2.27% |
Woodline Partners LP | 540,416 | $47,713,000 | 1.26% |
Cormorant Asset Management, LP | 600,000 | $52,974,000 | 1.26% |
RA Capital Management | 982,723 | $86,765,000 | 1.21% |
Logos Global Management LP | 150,000 | $13,244,000 | 1.14% |
Baker Brothers Advisors | 3,144,892 | $277,663,000 | 1.05% |
Ikarian Capital, LLC | 250,000 | $22,073,000 | 0.97% |
HighVista Strategies LLC | 11,954 | $1,055,000 | 0.67% |